Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × reolysin × Clear all

NCT04445844 2025-04-04

INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study

Phase 2 Active not recruiting

Triple Negative Breast Neoplasms